Metabolomics Market (Gas Chromatography, Capillary Electrophoresis, High Performance Liquid Chromatography, Ultra Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical Toxicology) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Press Release :
Global Metabolomics Market: Overview
In recent years, there is immense use of metabolomics in the identification and quantification of cellular metabolites. This factor is projected to stimulate the growth of the global metabolomics market during the forecast period of 2016 to 2024. Metabolomics can be defined as a study of chemical processes that involve metabolites. One of the key purposes of metabolomics is to gain direct functional data of the physiological state of an organism.
In recent years, all major sectors are witnessing advancement in technology. Similarly, molecular biology is one of the key fields that have experienced immense technological development in recent times. This factor, in turn, is driving the development of metabolomics field. At the same time, the developments in analytical equipment and software are driving the growth of metabolomics field. Several vendors in the global metabolomics market are increasing investment in research and development activities. Moreover, governments of numerous countries are taking initiatives to support these research activities. Thus, growing support from government bodies from all across the world is fueling the growth of the global metabolomics market.
The report performs the segmentation of the market for metabolomics on the basis of application, technique, and regions.
Development in Pharmaceutical Sector Fuels Market Growth
The global metabolomics market is projected to experience remarkable growth avenues in the upcoming period. This dynamic growth can be attributed to development in the drug discovery segment and other related sectors in the pharmaceutical industry. In recent years, pharmaceuticals, life sciences, and chemicals fields are witnessing tremendous development. Owing to these developments, one of the key sectors that experienced remarkable advantages is the healthcare sector. Customized medicines and personalized therapeutics are some of the examples of this advancement. All these events have also worked as a driving factor for the global metabolomics market.
Growing number of worldwide older population is stimulating the growth of the global metabolomics market. Besides, increased incidences of chronic diseases including diabetes, cancer, and others will push the market growth in the upcoming period. Based on technique, the global metabolomics market is divided into two parts, namely, detection techniques and separation technique. Of them, detection techniques is further segmented into mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR). Similarly, separation technique in the metabolomics market is bifurcated into capillary electrophoresis (CE), gas chromatography (GC), ultra performance liquid chromatography (UPLC), and high performance liquid chromatography (HPLC).
Biomarker discovery, drug assessment, clinical toxicology, and nutrigenomics are some of the key applications owing to which the global metabolomics market is projected to witness stupendous growth avenues during years ahead. Other applications of metabolomics include gas chromatography, capillary electrophoresis, high performance liquid chromatography, ultra performance liquid chromatography, nuclear magnetic resonance spectroscopy, and mass spectrometry.
Unawareness about Benefits among End-users Makes Market Growth Sluggish
Some factors are projected to slow down the growth of the global metabolomics market during forecast period of 2016 to 2024. Majority of end-user industries are unaware about the advantages of metabolomics. Owing to this unawareness, there is mixed approach among a wide range of population toward the use of these technologies. This aside, the metabolomics market is witnessing lack of skilled professionals to work in this field. These are some of the most important factors hindering the growth of the global metabolomics market.
Strategic Moves by Key Enterprises Support in Driving Market Revenues
The global metabolomics market is fragmented in nature. It includes many small, medium, and large-scale players. As a result, the competitive landscape of the market for metabolomics highly intense. Well-established vendors in the market are chasing various strategic moves such as mergers and acquisitions. These moves are helping enterprises to gain and maintain leading position in the global metabolomics market.
Many vendors in the global metabolomics market are growing efforts to strengthen their production capabilities. To achieve this purpose, several enterprises have launched new production units. Numerous players are investing in marketing of their products. All these activities are opening remarkable opportunities for the growth of the global metabolomics market.
North America Offers Stupendous Avenues for Market Growth
The global metabolomics market is spread across five key regions, namely, Europe, Asia Pacific, North America, Middle East and Africa, and Latin America. Of them, North America is one of the leading regions in this market. Presence of significant number of key players is one of the key reasons driving the market growth in this region. Besides, increased technological development and high product commercialization are some of the vital factors stimulating the growth of the metabolomics market.
Asia Pacific is estimated to show promising opportunities for the growth of metabolomics market in the upcoming period. In recent years, the region is witnessing increased number of older population. As a result, there is increased demand for superior quality pharmaceutical products in emerging economics such as India and China. This is working as a driving factor for the metabolomics market. Besides, presence of key players and support from the government bodies will further boost the market growth in Asia Pacific.
The list of key players in metabolomics market includes Agilent Technologies, Inc.(U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc.(Japan), Waters Corporation (U.S.), Metabolon, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), and Bio-Rad Laboratories, Inc.(U.S.).
Metabolomics is an omics sciences in systems biology and involves global valuation and validation of endogenous metabolites inside a biological system. With the technological advances in molecular biology, there has been significant development in the field of metabolomics. The developments analytical equipment and software have backed the development of metabolomics field. Similarly, increasing metabolomics research funding and government initiatives is a major driver for the growth of this market. Metabolomics science is used widely in biomarker discovery and drug assessment. Thus, the rapid development experienced by pharmaceutical and biotechnology sectors is supporting the growth of the metabolomics market. However, the dearth of skilled professionals in metabolomics science is expected to hamper the growth of the metabolomics market. Moreover, low adoption of advanced metabolomics products is the other factor deterring the growth of the metabolomics market.
Metabolomics is gaining importance as a tool in the life sciences since it is a relatively fast and precise technique that can be applied with either a particular focus or in an overall manner to gain new knowledge about biological systems. This research study analyzes the market for metabolomics in terms of revenue (US$ Mn). For the research, 2015 has been considered as the base year, while all forecasts have been provided from 2016 to 2024. The global metabolomics market is segmented into three segments as technique, applications, and geography. The market by technique is further divided as separation techniques and detection techniques. Separation techniques includes study of gas chromatography, capillary electrophoresis, high performance liquid chromatography (HPLC) and ultra-performance liquid chromatography (UPLC). The HPLC accounted for the highest share of metabolomics market by technique. Detection technique includes nuclear magnetic resonance spectroscopy (NMR), mass spectrometry (MS) and others. The market by application includes drug assessment, biomarker discovery, nutrigenomics, clinical toxicology and others. The market by geography is divided into five regions as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
The market overview section of the report demonstrates major market dynamics such as drivers, restraints, and opportunities that influence the current and future status of the industry. Porter’s five forces analysis provides information about the competitiveness of the industry. Moreover, the market attractiveness and competitive landscape provided in the market overview gives information about the lucrative markets for investment and major players in this market, respectively. The report concludes with the company profiles section, which includes key information about major players in the market such as financial overview, business strategies, and recent developments.
Major players in this market are Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc.(U.S.), Biocrates Life Sciences AG (Austria), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Human Metabolome Technologies, Inc.(Japan), LECO Corporation (U.S.), Metabolon, Inc. (U.S.), Bio-Rad Laboratories, Inc.(U.S.), and Bruker Corporation (U.S.)
Global Metabolomics market has been segmented as follows:
- Global Metabolomics Market, By Technique
- Separation Techniques
- Gas Chromatography (GC)
- Capillary Electrophoresis (CE)
- High Performance Liquid Chromatography (HPLC)
- Ultra Performance Liquid Chromatography (UPLC)
- Detection Techniques
- Nuclear Magnetic Resonance Spectroscopy (NMR)
- Mass Spectrometry (MS)
- Global Metabolomics Market, By Application
- Drug Assessment
- Biomarker Discovery
- Clinical toxicology
- Global Metabolomics Market, by Geography
- North America
- United States
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa